Document Detail


Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure.
MedLine Citation:
PMID:  12756157     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The dissemination of clinical practice guidelines often has not been accompanied by desired improvements in guideline adherence. This study evaluated interventions for implementing a new practice guideline advocating the use of beta-blockers for heart failure patients. METHODS AND RESULTS: This was a randomized controlled trial involving heart failure patients (n=169) with an ejection fraction < or =45% and no contraindications to beta-blockers. Patients' primary providers were randomized in a stratified design to 1 of 3 interventions: (1) control: provider education; (2) provider and patient notification: computerized provider reminders and patient letters advocating beta-blockers; and (3) nurse facilitator: supervised nurse to initiate and titrate beta-blockers. The primary outcome, the proportion of patients who were initiated or uptitrated and maintained on beta-blockers, analyzed by intention to treat, was achieved in 67% (36 of 54) of patients in the nurse facilitator group compared with 16% (10 of 64) in the provider/patient notification and 27% (14 of 51) in the control groups (P<0.001 for the comparisons between the nurse facilitator group and both other groups). The proportion of patients on target beta-blocker doses at the study end (median follow-up, 12 months) was also highest in the nurse facilitator group (43%) compared with the control (10%) and provider/patient notification groups (2%) (P<0.001). There were no differences in adverse events among groups. CONCLUSIONS: The use of a nurse facilitator was a successful approach for implementing a beta-blocker guideline in heart failure patients. The use of provider education, clinical reminders, and patient education was of limited value in this setting.
Authors:
Maria Ansari; Michael G Shlipak; Paul A Heidenreich; Denise Van Ostaeyen; Elizabeth C Pohl; Warren S Browner; Barry M Massie
Related Documents :
9236677 - Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart ra...
18725047 - Reduced heart rate multiscale entropy predicts death in critical illness: a study of ph...
2956397 - Enoximone (mdl 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, un...
22878177 - Empirical mode decomposition based detrended sample entropy in electroencephalography f...
10487167 - Photosensitive and nonphotosensitive electronic screen game-induced seizures.
19341177 - Prevalence of thyroid diseases and antithyroid antibodies in women with rheumatoid arth...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2003-05-19
Journal Detail:
Title:  Circulation     Volume:  107     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-06-10     Completed Date:  2003-06-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2799-804     Citation Subset:  AIM; IM    
Affiliation:
Cardiology Division, San Francisco VA Medical Center, 4150 Clement St, San Francisco, Calif 94121, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Cohort Studies
Drug Utilization / statistics & numerical data*
Guideline Adherence / statistics & numerical data*
Health Personnel / education,  standards
Heart Failure / drug therapy*
Humans
Information Dissemination
Nurse Practitioners / standards
Outcome and Process Assessment (Health Care) / statistics & numerical data*
Patient Education as Topic / methods,  standards
Physician's Practice Patterns / statistics & numerical data*
Reminder Systems
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists
Comments/Corrections
Comment In:
ACP J Club. 2004 Jan-Feb;140(1):22   [PMID:  14711293 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Microvascular filtration is increased in postural tachycardia syndrome.
Next Document:  Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study.